146 related articles for article (PubMed ID: 23429988)
1. Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis.
Michel L; Jean-Louis F; Begue E; Bensussan A; Bagot M
Blood; 2013 Feb; 121(8):1477-8. PubMed ID: 23429988
[No Abstract] [Full Text] [Related]
2. CD158K/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of Sézary syndrome.
Ortonne N; Le Gouvello S; Mansour H; Poillet C; Martin N; Delfau-Larue MH; Leroy K; Farcet JP; Bagot M; Bensussan A
J Invest Dermatol; 2008 Feb; 128(2):465-72. PubMed ID: 17703174
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients.
Bensussan A; Remtoula N; Sivori S; Bagot M; Moretta A; Marie-Cardine A
J Invest Dermatol; 2011 Apr; 131(4):969-76. PubMed ID: 21191411
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.
Boonk SE; Zoutman WH; Putter H; Ram-Wolff C; Felcht M; Klemke CD; Ranki A; Quaglino P; Whittaker S; Bagot M; Willemze R; Vermeer MH
J Invest Dermatol; 2017 Mar; 137(3):754-757. PubMed ID: 27984038
[No Abstract] [Full Text] [Related]
5. CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.
Poszepczynska-Guigné E; Schiavon V; D'Incan M; Echchakir H; Musette P; Ortonne N; Boumsell L; Moretta A; Bensussan A; Bagot M
J Invest Dermatol; 2004 Mar; 122(3):820-3. PubMed ID: 15086570
[TBL] [Abstract][Full Text] [Related]
6. Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Wong HK; Gibson H; Hake T; Geyer S; Frederickson J; Marcucci G; Caligiuri MA; Porcu P; Mishra A
J Invest Dermatol; 2015 Aug; 135(8):2084-2092. PubMed ID: 25806852
[TBL] [Abstract][Full Text] [Related]
7. T-plastin (PLS3) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression.
Tang N; Gibson H; Germeroth T; Porcu P; Lim HW; Wong HK
Br J Dermatol; 2010 Feb; 162(2):463-6. PubMed ID: 19995369
[TBL] [Abstract][Full Text] [Related]
8. CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides.
Ortonne N; Le Gouvello S; Tabak R; Marie-Cardine A; Setiao J; Berrehar F; Nghe-Tang A; Martin N; Bagot M; Bensussan A
Exp Dermatol; 2012 Jun; 21(6):461-3. PubMed ID: 22621189
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic expression of CD158k/p140/KIR3DL2 in Sézary patients.
Musette P; Michel L; Jean-Louis F; Bagot M; Bensussan A
Blood; 2003 Feb; 101(3):1203. PubMed ID: 12529298
[No Abstract] [Full Text] [Related]
10. CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.
Moins-Teisserenc H; Daubord M; Clave E; Douay C; Félix J; Marie-Cardine A; Ram-Wolff C; Maki G; Beldjord K; Homyrda L; Michel L; Bensussan A; Toubert A; Bagot M
J Invest Dermatol; 2015 Jan; 135(1):247-257. PubMed ID: 25158034
[TBL] [Abstract][Full Text] [Related]
11. CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome.
Vergnolle I; Douat-Beyries C; Boulinguez S; Rieu JB; Vial JP; Baracou R; Boudot S; Cazeneuve A; Chaugne S; Durand M; Estival S; Lablanche N; Nicolau-Travers ML; Tournier E; Lamant L; Vergez F
Blood Adv; 2022 Mar; 6(6):1813-1825. PubMed ID: 34570200
[TBL] [Abstract][Full Text] [Related]
12. NKp46-specific expression on skin-resident CD4(+) lymphocytes in mycosis fungoides and Sézary syndrome.
Schneider P; Plassa LF; Ratajczak P; Leboeuf C; Verneuil L; Battistella M; Bensussan A; Bagot M; Janin A
J Invest Dermatol; 2014 Feb; 134(2):574-578. PubMed ID: 23900021
[No Abstract] [Full Text] [Related]
13. Significance of circulating T-cell clones in Sezary syndrome.
Ortonne N; Huet D; Gaudez C; Marie-Cardine A; Schiavon V; Bagot M; Musette P; Bensussan A
Blood; 2006 May; 107(10):4030-8. PubMed ID: 16418328
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis.
van Doorn R; Dijkman R; Vermeer MH; Out-Luiting JJ; van der Raaij-Helmer EM; Willemze R; Tensen CP
Cancer Res; 2004 Aug; 64(16):5578-86. PubMed ID: 15313894
[TBL] [Abstract][Full Text] [Related]
15. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
Hameetman L; van der Fits L; Zoutman WH; Out-Luiting JJ; Siegal G; de Esch IJ; Vermeer MH; Tensen CP
Oncotarget; 2015 Oct; 6(31):31868-76. PubMed ID: 26376612
[TBL] [Abstract][Full Text] [Related]
16. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry.
Bahler DW; Hartung L; Hill S; Bowen GM; Vonderheid EC
Cytometry B Clin Cytom; 2008 May; 74(3):156-62. PubMed ID: 18061949
[TBL] [Abstract][Full Text] [Related]
17. SC5 mAb represents a unique tool for the detection of extracellular vimentin as a specific marker of Sezary cells.
Huet D; Bagot M; Loyaux D; Capdevielle J; Conraux L; Ferrara P; Bensussan A; Marie-Cardine A
J Immunol; 2006 Jan; 176(1):652-9. PubMed ID: 16365461
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Sézary syndrome in a patient with generalized pruritus based on early molecular study and flow cytometry.
Bowen GM; Stevens SR; Dubin HV; Siddiqui J; Cooper KD
J Am Acad Dermatol; 1995 Oct; 33(4):678-80. PubMed ID: 7673506
[No Abstract] [Full Text] [Related]
19. From single-cell signature to prognostic factors: the case of Sézary syndrome.
Scala E; Narducci MG; Russo G
Expert Rev Clin Immunol; 2012 Nov; 8(8):699-701. PubMed ID: 23167680
[No Abstract] [Full Text] [Related]
20. Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma.
Bégué E; Jean-Louis F; Bagot M; Jauliac S; Cayuela JM; Laroche L; Parquet N; Bachelez H; Bensussan A; Courtois G; Michel L
Blood; 2012 Jul; 120(1):143-54. PubMed ID: 22627769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
